Gynaecological Follow-up of a Subset of HPV-015 Study Subjects
This study is intended to provide up to a maximum of four years of annual oncogenic human
papillomavirus (HPV) DNA testing and cervical cytology examination for NCT00294047 study
subjects who displayed normal cervical cytology but tested positive for oncogenic HPV
infection at their concluding NCT00294047 study visit.
Women who were pregnant at their concluding NCT00294047 study visit may also be included in
this study, as no cervical sample could be collected at that visit.
The objectives and outcome measures of the primary phase (NCT00294047) are presented in a
separate protocol posting.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society